Accelerate Diagnostics Inc (AXDX)
0.93
-0.02
(-1.62%)
USD |
NASDAQ |
Apr 26, 16:00
0.93
0.00 (0.00%)
After-Hours: 20:00
Accelerate Diagnostics Enterprise Value: 44.09M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 25, 2024 | 44.09M |
April 24, 2024 | 43.78M |
April 23, 2024 | 44.19M |
April 22, 2024 | 42.83M |
April 19, 2024 | 42.22M |
April 18, 2024 | 40.29M |
April 17, 2024 | 39.56M |
April 16, 2024 | 41.28M |
April 15, 2024 | 43.32M |
April 12, 2024 | 42.85M |
April 11, 2024 | 43.11M |
April 10, 2024 | 42.89M |
April 09, 2024 | 42.24M |
April 08, 2024 | 43.47M |
April 05, 2024 | 41.74M |
April 04, 2024 | 41.80M |
April 03, 2024 | 43.22M |
April 02, 2024 | 43.98M |
April 01, 2024 | 42.88M |
March 28, 2024 | 45.06M |
March 27, 2024 | 45.49M |
March 26, 2024 | 44.41M |
March 25, 2024 | 45.27M |
March 22, 2024 | 43.68M |
March 21, 2024 | 43.48M |
Date | Value |
---|---|
March 20, 2024 | 43.68M |
March 19, 2024 | 43.28M |
March 18, 2024 | 43.47M |
March 15, 2024 | 42.87M |
March 14, 2024 | 43.88M |
March 13, 2024 | 45.50M |
March 12, 2024 | 44.89M |
March 11, 2024 | 46.72M |
March 08, 2024 | 46.92M |
March 07, 2024 | 45.50M |
March 06, 2024 | 45.91M |
March 05, 2024 | 45.10M |
March 04, 2024 | 44.49M |
March 01, 2024 | 43.27M |
February 29, 2024 | 43.58M |
February 28, 2024 | 42.41M |
February 27, 2024 | 42.06M |
February 26, 2024 | 43.07M |
February 23, 2024 | 43.27M |
February 22, 2024 | 42.87M |
February 21, 2024 | 46.72M |
February 20, 2024 | 47.53M |
February 16, 2024 | 47.53M |
February 15, 2024 | 47.73M |
February 14, 2024 | 48.34M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
39.56M
Minimum
Apr 17 2024
1.291B
Maximum
Jul 03 2019
442.34M
Average
433.35M
Median
Enterprise Value Benchmarks
Achieve Life Sciences Inc | 157.87M |
ENDRA Life Sciences Inc | -0.1293M |
Tivic Health Systems Inc | -1.818M |
Spectral AI Inc | 23.19M |
Perspective Therapeutics Inc | 931.55M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -13.00M |
Revenue (Quarterly) | 3.027M |
Total Expenses (Quarterly) | 13.76M |
EPS Diluted (Quarterly) | -0.81 |
Gross Profit Margin (Quarterly) | 20.91% |
Profit Margin (Quarterly) | -429.4% |
Earnings Yield | -582.8% |
Normalized Earnings Yield | -481.84 |